Henry P. Porter Jr., Ph.D., recently established a new scholarship endowment at the Marshall University Joan C. Edwards ...
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
General contractor JE Dunn + Hutton has broken ground on the Wichita Biomedical Campus (WBC), a $172.5 million project rising eight stories and totaling 350,000 square feet in Wichita. The development ...
The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...
He's also a member of the National Athletic Trainers Association Hall of Fame and the Pennsylvania Athletic Training Hall of ...
Transgender residents living across the sprawling Kansas City metro are straddling two states pushing to restrict their ...
The Alaska Native Science and Engineering Program has helped thousands of students get their footing in science, engineering ...
Jon Klein, a 40-year veteran of medical and higher education experience at the University of Louisville, has been named the ...
At issue is the physical area the state analyzed in a 2023 health study near the 29th and Grove contamination site.
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
6d
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s diseaseONAPGO is a wearable subcutaneous infusion ...
When Dr. Nathan Gause began his first year of medical school, he was stunned to discover he was the only Black male student in the entire program at University of South Alabama. As he progressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback